# OnCo record exai-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/exai-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "exai-bio" ;
  schema:name "Exai Bio"@en ;
  schema:description "Exai Bio is building blood tests that look for small pieces of RNA made only by tumours, rather than tumour DNA, and uses artificial intelligence to find cancer early from a routine blood draw."@en ;
  schema:url <https://onco.cc/companies/exai-bio/>, <https://www.exai.bio/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.exai.bio/>, <https://www.exai.bio/news/exai-bio-secures-67-5-million-series-a>, <https://www.exai.bio/news> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/rna-seq/>, <https://onco.cc/technologies/mced/> .
